Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 5 studies | 21% ± 2% | |
| endothelial cell | 4 studies | 20% ± 4% | |
| epithelial cell | 4 studies | 18% ± 1% | |
| non-classical monocyte | 3 studies | 24% ± 9% | |
| type I pneumocyte | 3 studies | 19% ± 1% | |
| endothelial cell of lymphatic vessel | 3 studies | 19% ± 4% |
Insufficient scRNA-seq data for expression of PARP12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1484.81 | 1445 / 1445 | 100% | 40.05 | 183 / 183 |
| stomach | 100% | 1421.03 | 359 / 359 | 100% | 33.28 | 286 / 286 |
| intestine | 100% | 2398.67 | 966 / 966 | 100% | 32.62 | 526 / 527 |
| lung | 100% | 3988.49 | 578 / 578 | 100% | 35.52 | 1152 / 1155 |
| prostate | 100% | 1972.74 | 245 / 245 | 100% | 25.31 | 500 / 502 |
| ovary | 100% | 1448.36 | 180 / 180 | 100% | 39.19 | 428 / 430 |
| pancreas | 100% | 1478.85 | 328 / 328 | 99% | 38.78 | 177 / 178 |
| breast | 100% | 2087.38 | 459 / 459 | 99% | 34.28 | 1111 / 1118 |
| thymus | 100% | 1964.79 | 653 / 653 | 99% | 25.36 | 598 / 605 |
| uterus | 100% | 2059.04 | 170 / 170 | 99% | 39.41 | 453 / 459 |
| kidney | 100% | 1987.94 | 89 / 89 | 99% | 24.10 | 888 / 901 |
| liver | 100% | 1651.29 | 226 / 226 | 99% | 24.00 | 400 / 406 |
| bladder | 100% | 1709.71 | 21 / 21 | 98% | 35.87 | 496 / 504 |
| adrenal gland | 100% | 1532.62 | 258 / 258 | 91% | 12.89 | 209 / 230 |
| skin | 100% | 1477.05 | 1807 / 1809 | 86% | 23.72 | 408 / 472 |
| brain | 71% | 428.66 | 1871 / 2642 | 66% | 11.37 | 465 / 705 |
| adipose | 100% | 2219.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 40.53 | 29 / 29 |
| spleen | 100% | 4349.12 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 41.19 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 13.44 | 1 / 1 |
| heart | 99% | 921.83 | 855 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1329.49 | 1324 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 1840.95 | 905 / 929 | 0% | 0 | 0 / 0 |
| muscle | 82% | 518.97 | 661 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 65% | 8.74 | 52 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0070213 | Biological process | protein auto-ADP-ribosylation |
| GO_0005634 | Cellular component | nucleus |
| GO_0016779 | Molecular function | nucleotidyltransferase activity |
| GO_1990404 | Molecular function | NAD+-protein ADP-ribosyltransferase activity |
| GO_0003950 | Molecular function | NAD+ ADP-ribosyltransferase activity |
| GO_0140803 | Molecular function | NAD+- protein-cysteine ADP-ribosyltransferase activity |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | PARP12 |
| Protein name | Poly (ADP-ribose) polymerase family, member 12, isoform CRA_b (Zinc finger CCCH type domain containing 1) Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1) Poly [ADP-ribose] polymerase (PARP) (EC 2.4.2.-) Poly (ADP-ribose) polymerase family, member 12, isoform CRA_a (Poly(ADP-ribose) polymerase family member 12) Poly(ADP-ribose) polymerase family member 12 |
| Synonyms | tcag7.1054 ZC3HDC1 hCG_1811077 |
| Description | FUNCTION: Mono-ADP-ribosyltransferase that mediates mono-ADP-ribosylation of target proteins. . |
| Accessions | H7C4L8 Q9H0J9 ENST00000484111.1 H7C4Z9 ENST00000489809.5 A4D1T0 G5E9U9 ENST00000473341.5 ENST00000491598.5 H7C4T3 ENST00000263549.8 |
